Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001493152-24-044038
Filing Date
2024-11-07
Accepted
2024-11-07 17:00:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13ga.htm SC 13G/A 66359
  Complete submission text file 0001493152-24-044038.txt   67819
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Subject) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89290 | Film No.: 241436873
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CERECOR INC. 400 E. PRATT STREET, SUITE 606 BALTIMORE MD 21202
Business Address
Crutcher Patrick J (Filed by) CIK: 0001754540 (see all company filings)

Type: SC 13G/A